Literature DB >> 18451071

Utility of serum cystatin C as a clinical measure of renal function in dogs.

Astrid Wehner1, Katrin Hartmann, Johannes Hirschberger.   

Abstract

A human kit for cystatin C determination was evaluated for use with canine sera. A reference range was also established. The association between cystatin C and glomerular filtration rate (GFR) was evaluated in 60 dogs with various diseases, by using exogenous creatinine plasma clearance (ECPC) as a measure of GFR. The correlation between cystatin C and ECPC (correlation coefficient [r] = -0.630; P<0.001) was stronger than the correlation between serum creatinine and ECPC (r = -0.572; P<0.001). Nonrenal diseases (e.g., neoplasia, infection) did not influence serum cystatin C concentration. Test sensitivity was significantly better (P<0.001) for cystatin C (76%) than for creatinine (65%). Specificities for the two tests were 87% and 91%, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18451071     DOI: 10.5326/0440131

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  15 in total

1.  Biomarkers and renal arterial resistive index in dogs naturally infected with Leishmania infantum.

Authors:  Fabiano de Oliveira Frazilio; Fernando de Almeida Borges; Alda Izabel de Souza; Mariana Isa Poci Palumbo; Carlos Alberto do Nascimento Ramos; Diogo Helney Freire; André Luiz Baptista Galvão; Mariana Green de Freitas; Fernanda Battistotti Barbosa
Journal:  Parasitol Res       Date:  2018-08-01       Impact factor: 2.289

Review 2.  An overview of glomerular filtration rate testing in dogs and cats.

Authors:  Vanessa E Von Hendy-Willson; Barrak M Pressler
Journal:  Vet J       Date:  2010-06-11       Impact factor: 2.688

3.  Effect of age, sex, and breed on serum cystatin C and creatinine concentrations in dogs.

Authors:  Naoki Iwasa; Satoshi Takashima; Tatsuo Iwasa; Rie Kumazawa; Saki Nomura; Sara Asami; Mamu Shimizu; Yui Kobatake; Naohito Nishii
Journal:  Vet Res Commun       Date:  2022-01-21       Impact factor: 2.459

4.  Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease.

Authors:  J A Hall; M Yerramilli; E Obare; M Yerramilli; D E Jewell
Journal:  J Vet Intern Med       Date:  2014-09-17       Impact factor: 3.333

5.  A mixed grape and blueberry extract is safe for dogs to consume.

Authors:  Anne-Sophie Martineau; Véronique Leray; Anne Lepoudere; Géraldine Blanchard; Julien Bensalem; David Gaudout; Khadija Ouguerram; Patrick Nguyen
Journal:  BMC Vet Res       Date:  2016-08-03       Impact factor: 2.741

6.  Evaluation of serum cystatin-C and symmetric dimethylarginine concentrations in dogs with heart failure from chronic mitral valvular insufficiency.

Authors:  Bom-Sul Choi; Hyeong-Sun Moon; Sang-Hyuk Seo; Changbaig Hyun
Journal:  J Vet Med Sci       Date:  2016-09-30       Impact factor: 1.267

7.  Effects of Oral Prednisone Administration on Serum Cystatin C in Dogs.

Authors:  J Muñoz; P Soblechero; F J Duque; B Macías-García; P Ruiz; C Zaragoza; R Barrera
Journal:  J Vet Intern Med       Date:  2017-09-18       Impact factor: 3.333

8.  Comparison of the diagnostic value of symmetric dimethylarginine, cystatin C, and creatinine for detection of decreased glomerular filtration rate in dogs.

Authors:  Lena Pelander; Jens Häggström; Anders Larsson; Harriet Syme; Jonathan Elliott; Reidun Heiene; Ingrid Ljungvall
Journal:  J Vet Intern Med       Date:  2019-02-21       Impact factor: 3.333

Review 9.  Cystatin C: a new renal marker and its potential use in small animal medicine.

Authors:  L Ghys; D Paepe; P Smets; H Lefebvre; J Delanghe; S Daminet
Journal:  J Vet Intern Med       Date:  2014-05-09       Impact factor: 3.333

10.  Evaluation of Cystatin C for the Detection of Chronic Kidney Disease in Cats.

Authors:  L F E Ghys; D Paepe; H P Lefebvre; B S Reynolds; S Croubels; E Meyer; J R Delanghe; S Daminet
Journal:  J Vet Intern Med       Date:  2016-07       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.